Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
BRONCHIECTASIS REGISTRATION CRITERIA : SPECIALIST INITIATION OF TREATMENT AND FOR ANY SIGNIFICANT INCREASES IN DOSAGES OR ADDITION OF MEDICATION. PLEASE SEE ACCEPTANCE CRITERIA FOR CO-EXISTING CONDITIONS (FOR EXAMPLE ASTHMA, COPD) FOR ORAL AND INHALED CORTICOSTEROIDS AND OTHER BRONCHODILATORS, PLEASE SEE REGISTRATION CRITERIA FOR ASTHMA OR COPD ANTIBIOTICS TO BE REGISTERED FOR 14 DAYS AS PER ALGORITHM Drug Class Active Ingredient Trade Name Penicillins Amoxicillin (Trihydrate) Cap 250 MG IPCAMOX 250MG CAP ALLMOX 250MG CAP AMOXICAP 250MG CAP AUSTELL-AMOXICILLIN 250MG XERACIL 250MG CAPS MOXYMAX 250MG CAP BETAMOX 250MG CAP PROMOXIL 250MG CAP A-LENNON AMOXYCILLIN 250M MOXYPEN 250MG CAP MAXCIL 250MG CAP AMOCILLIN 250MG CAP MOXAN 250MG CAP AMOCAS 250MG CAP MYMOX 250MG CAP MOXYMAX 250MG CAP Amoxicillin (Trihydrate) Cap 500 MG ALLMOX 500MG CAP XERACIL 500MG CAP BETAMOX 500MG CAP MOXYMAX 500MG CAP MAXCIL 500MG CAP PROMOXIL 500MG CAP AMOCILLIN 500MG CAP MOXYPEN 500MG CAP RANMOXY 500MG CAP MOXAN 500MG CAP Tetracyclines Doxycycline Hyclate Cap 100 MG A-LENNON DOXYCYCLINE HCL CYCLIDOX 100MG CAP DOXYCYL 100MG CAP PRIOR TO CHRONIC REGISTRATION, ALL FORMULARY DRUGS ARE SUBJECT TO SCHEME RULES ,MAXIMUM MEDICAL AID PRICE (MMAP), CLINICAL PROTOCOLS AND CHANGES IN PRODUCTS AND PRICES.